Hypogonadism Completed Phase 3 Trials for Choriogonadotropin alfa (DB00097)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs